A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

NCT00428597 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

171

Enrollment

INDUSTRY

Sponsor class

Stopped Refer to Detailed Description.

Conditions

Carcinoma, Islet Cell
Carcinoma, Pancreas

Interventions

DRUG: sunitinib malate
DRUG: Placebo

Sponsor

Pfizer